Author Affiliation: Los Angeles County Department of Health Services, Los Angeles, California.
Over the last 2 years, the journal has published several articles describing the harms of long-term opioid use for chronic nonmalignant pain, especially when prescribed at high doses. For example, Gomes et al,1 in an analysis of patients who received opioid medication from the Ontario publicly funded prescription coverage program, found that patients who receive a daily dose of 20 mg of morphine or its equivalent were more likely to die of an opioid-related cause. Doses greater than 200 mg of morphine or its equivalent were associated with an almost tripling of the risk of opioid-related death compared with persons taking less than 20 mg of morphine or its equivalent.
Katz MH. Opioid Prescriptions for Chronic Nonmalignant Pain: Driving on a Dangerous Road. JAMA Intern Med. 2013;173(3):178. doi:10.1001/jamainternmed.2013.1838
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: